Finance
Results: 16921-16932 of 49596

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule







